BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26849445)

  • 1. Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines.
    Espino FE; Bibit JA; Sornillo JB; Tan A; von Seidlein L; Ley B
    PLoS One; 2016; 11(2):e0148172. PubMed ID: 26849445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
    Ley B; Winasti Satyagraha A; Rahmat H; von Fricken ME; Douglas NM; Pfeffer DA; Espino F; von Seidlein L; Henriques G; Oo NN; Menard D; Parikh S; Bancone G; Karahalios A; Price RN
    PLoS Med; 2019 Dec; 16(12):e1002992. PubMed ID: 31834890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.
    Henriques G; Phommasone K; Tripura R; Peto TJ; Raut S; Snethlage C; Sambo I; Sanann N; Nguon C; Adhikari B; Pongvongsa T; Imwong M; von Seidlein L; Day NP; White NJ; Dondorp AM; Newton P; Ley B; Mayxay M
    Malar J; 2018 Jun; 17(1):243. PubMed ID: 29929514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
    Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
    PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
    Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
    Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells.
    Baird JK; Dewi M; Subekti D; Elyazar I; Satyagraha AW
    Transl Res; 2015 Jun; 165(6):677-88. PubMed ID: 25312015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
    Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
    Brito MA; Peixoto HM; Almeida AC; Oliveira MR; Romero GA; Moura-Neto JP; Singh N; Monteiro WM; Lacerda MV
    Rev Soc Bras Med Trop; 2016; 49(4):446-55. PubMed ID: 27598631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
    Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
    PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
    Satyagraha AW; Sadhewa A; Elvira R; Elyazar I; Feriandika D; Antonjaya U; Oyong D; Subekti D; Rozi IE; Domingo GJ; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004457. PubMed ID: 26894297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
    Abdul-Ghani R; Mahdy MA; Saif-Ali R; Alkubati SA; Alqubaty AR; Al-Mikhlafy AA; Al-Eryani SM; Al-Mekhlafi AM; Alhaj A
    Malar J; 2016 Jun; 15():327. PubMed ID: 27329471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti.
    von Fricken ME; Weppelmann TA; Eaton WT; Masse R; Beau de Rochars MV; Okech BA
    Am J Trop Med Hyg; 2014 Jul; 91(1):77-80. PubMed ID: 24778197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.
    Tsegaye A; Golassa L; Mamo H; Erko B
    Malar J; 2014 Nov; 13():438. PubMed ID: 25406667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.
    Adu-Gyasi D; Asante KP; Newton S; Dosoo D; Amoako S; Adjei G; Amoako N; Ankrah L; Tchum SK; Mahama E; Agyemang V; Kayan K; Owusu-Agyei S
    PLoS One; 2015; 10(4):e0125796. PubMed ID: 25885097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
    Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
    PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh.
    Ley B; Alam MS; O'Donnell JJ; Hossain MS; Kibria MG; Jahan N; Khan WA; Thriemer K; Chatfield MD; Price RN; Richards JS
    PLoS One; 2017; 12(1):e0169930. PubMed ID: 28121993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda.
    De Niz M; Eziefula AC; Othieno L; Mbabazi E; Nabukeera D; Ssemmondo E; Gonahasa S; Tumwebaze P; Diliberto D; Maiteki-Sebuguzi C; Staedke SG; Drakeley C
    Malar J; 2013 Jun; 12():210. PubMed ID: 23782846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.
    Pal S; Myburgh J; Bansil P; Hann A; Robertson L; Gerth-Guyette E; Ambler G; Bizilj G; Kahn M; Zobrist S; Manis MR; Styke NA; Allan V; Ansbro R; Akingbade T; Bryan A; Murphy SC; Kublin JG; Layton M; Domingo GJ
    PLoS One; 2021; 16(9):e0257560. PubMed ID: 34543346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests.
    Bancone G; Chu CS; Chowwiwat N; Somsakchaicharoen R; Wilaisrisak P; Charunwatthana P; Bansil P; McGray S; Domingo GJ; Nosten FH
    Am J Trop Med Hyg; 2015 Apr; 92(4):818-824. PubMed ID: 25646252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
    Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
    Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.